The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Padam Dugar & Others
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Colinz Laboratories disclosed that four persons (Padam Dugar, Annjana Dugar, Likhitta Dugar, and Antariksh Dugar) acquired 3,78,000 equity shares (15.01% of total capital) on May 21, 2026 through an off-market transaction. Prior to this acquisition, none of the acquirers held any shares in the company. Padam Dugar acquired the largest chunk with 3,16,000 shares (12.54%), while the other three acquired 40,000, 11,000 and 11,000 shares respectively. The acquirers confirmed they do not belong to the Promoter/Promoter group. The total share capital of the company is Rs.2,51,91,000 divided into 25,19,100 equity shares of Rs.10 each.
The acquisition represents a 15.01% stake purchase by non-promoter individuals, which is significant as it crosses the 10% substantial acquisition threshold under SAST regulations. This may trigger further regulatory requirements and could signal potential intent to build a larger position, which investors should monitor closely.